Claudin-low is a more recently identified intrinsic subtype of BC characterized by low expression of cell–cell adhesion molecules (claudins 3, 4, and 7; occluding; and E-cadherin) highly enriched in mesenchymal tracts and stem-cell characteristics. This evidence concerns the gene CLDN3 and breast cancer.